Table 2:

Procedural parameters, complications, follow-up, and outcome

ParameterNo. (relative frequency) / Mean ± SD
Selected feeder for embolization
 Middle meningeal artery86 (65.2%)
 Occipital artery31 (23.5%)
 Others14 (10.6%)
No. of embolization positions
 1103 (78.0%)
 224 (18.2%)
 34 (3.0%)
Embolization technique
 Onyx transarterial76 (57.6%)
 Onyx transarterial combined with venous balloon protection28 (21.2%)
 Onyx transarterial with a dual-lumen balloon catheter19 (14.4%)
 Onyx transvenous combined with coiling3 (2.3%)
 Others7 (5.3%)
Complications
 Overall complications11 (8.3%)
 Asymptomatic complications6 (4.5%)
 Transient symptomatic complications3 (2.3%)
 Permanent complicationsa2 (1.5%)
Follow-up
 Follow-up period (mo)23.6 ± 23.5
 Total follow-up time (patient yr)216.3
Angiographic outcome
 Initial complete angiographic occlusion86 (78.2%)
 Spontaneous occlusion after subtotal endovascular occlusion14 (12.7%)
 Time period from last treatment to diagnosis of spontaneous occlusion (months)6.6 ± 8.1
 Overall complete occlusion at last examination100 (90.9%)
 Recurrence4 (3.6%)
Clinical outcome
 Preinterventional mRS score0.8 ± 0.9
 Postinterventional mRS score at discharge0.7 ± 1.1
 Postinterventional mRS score at 6 mo after treatment0.4 ± 0.9
 Complete symptom remission after treatment73 (66.4%)
 Symptom relief after treatment32 (29.1%)
 Stable symptoms after treatment3 (2.7%)
 Worsening of symptoms after treatment2 (1.8%)
Treatment successb90 (81.8%)
  • a Both permanent complications were lethal intracerebral hemorrhages.

  • b Defined as complete symptom remission for low-grade DAVFs (no cortical venous reflux/Cognard I–IIa) and complete angiographic occlusion for high-grade DAVFs (to presence of cortical venous reflux/Cognard IIa+b to IV).